In our analysis, the highest frequency of iChr12p amplification was shown in NSGCTs, such as yolk sac tumors (65%), embryonal carcinomas (71%), etc. Furthermore, there was no difference in VDR expression on IHC between metastatic and non-metastatic TGCTs [64]. The gene discussed is VDR; the disease is embryonal carcinoma.